MARKET

VOGX

VOGX

Vogenx
NASDAQ
20.25
+0.33
+1.66%
After Hours: 20.25 0 0.00% 19:30 10/30 EDT
OPEN
19.63
PREV CLOSE
19.92
HIGH
20.74
LOW
19.24
VOLUME
45.08K
TURNOVER
--
52 WEEK HIGH
38.41
52 WEEK LOW
12.95
MARKET CAP
300.82M
P/E (TTM)
-193.4097
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VOGX last week (1019-1023)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 10/22 12:05
Why QuantumScape Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/22 09:08
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 10/21 21:05
Weekly Report: what happened at VOGX last week (1012-1016)?
Weekly Report · 10/19 10:34
Vogenx initiates Phase 2b EMERGE study of mizagliflozin
TipRanks · 10/15 20:40
Vogenx Initiates EMERGE, Phase 2b Clinical Trial Evaluating Mizagliflozin For Treatment Of Post-Bariatric Hypoglycemia
Benzinga · 10/15 20:37
Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia
Barchart · 10/15 15:35
More
About VOGX
Vogenx, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The Company's primary objective is to advance its lead product candidate, mizagliflozin, is an orally administered, minimally absorbed small molecule drug candidate in development for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome, or GDCS. Mizagliflozin is a selective inhibitor of SGLT1, a glucose transporter present in the gastrointestinal tract responsible for transporting dietary glucose into the bloodstream. Its VGX-2857 is a novel small molecule-based product candidate that is orally available. VGX-2857 is a combination of two novel small molecules that have demonstrated the potential to aid in weight loss in one fixed dosage form.

Webull offers Vogenx stock information, including NASDAQ: VOGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VOGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VOGX stock methods without spending real money on the virtual paper trading platform.